Resolute Integrity™ RSINT40038UXRecalls & reported problems
Medtronic, Inc. · Stent RSINT40038UX MicroTrac 4.00X38RX · Class 3 · Implant
All models of Resolute Integrity (52)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169037267), received between Jun 7, 2019 and Jul 3, 2019 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Use of Device Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Use of Device Problem1
Patient problems
- No Consequences Or Impact To Patient1
- Perforation1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJul 3, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING A PROCEDURE A RESOLUTE INTEGRITY RX CORONARY, DRUG ELUTING STENT WAS USED TO TREAT A LESION IN THE MID LEFT ANTERIOR DESCENDING(LAD) ARTERY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS NOT PERFORMED. IT IS REPORTED THAT AN EXPIRED STENT WAS IMPLANTED IN THE PATIENT. THE PRODUCT EXPIRED ON THE 25TH OF MAY 2019. THE PATIENT IS ALIVE WITH NO INJURY. NO INTERVENTION AS A RESULT OF EXPIRED PRODUCT. HOWEVER IT WAS REPORTED THAT THE PATIENT ALSO RECEIVED A RSINT40038UX ALSO IN THE MID LAD. THE PATIENT WAS NOTED TO HAVE A PERFORATION OF THE ARTERY AFTER SECOND STENT DEPLOYMENT. TWO NON-MEDTRONIC COVERED STENTS WERE PLACED IN THE MID LAD DURING THIS CASE. PT REMAINED IN THE HOSPITAL OVER THE WEEKEND AND RETURNED TO CATH LAB FOR REPEAT ANGIOGRAPHY. PATIENT WAS NOTED TO HAVE INADEQUATE SEALING OF PERFORATION. A 4.0 NON-MEDTRONIC STENT WAS PLACED, PATIENT LEFT LAB IN STABLE CONDITION. MD THAT PERFORMED INTERVENTION STATES PATIENT ¿DOING WELL¿.
Patient problems: Perforation
MAUDE report 8757265 ↗MalfunctionJun 7, 2019Use of Device Problem; Use of Device Problem
DURING A PROCEDURE A RESOLUTE INTEGRITY RX CORONARY, DRUG ELUTING STENT WAS USED TO TREAT A LESION IN THE MID LEFT ANTERIOR DESCENDING(LAD) ARTERY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS NOT PERFORMED. IT IS REPORTED THAT AN EXPIRED STENT WAS IMPLANTED IN THE PATIENT. THE PRODUCT EXPIRED ON THE 25TH OF MAY 2019. THE PATIENT IS ALIVE WITH NO INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8677790 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page